200 related articles for article (PubMed ID: 30718056)
1. Wnt signaling in intestinal inflammation.
Moparthi L; Koch S
Differentiation; 2019; 108():24-32. PubMed ID: 30718056
[TBL] [Abstract][Full Text] [Related]
2. Roles of nAChR and Wnt signaling in intestinal stem cell function and inflammation.
Takahashi T
Int Immunopharmacol; 2020 Apr; 81():106260. PubMed ID: 32007796
[TBL] [Abstract][Full Text] [Related]
3. Extrinsic control of Wnt signaling in the intestine.
Koch S
Differentiation; 2017; 97():1-8. PubMed ID: 28802143
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in IκBα in the intestinal epithelium leads to spontaneous inflammation and mediates apoptosis in the gut.
Mikuda N; Schmidt-Ullrich R; Kärgel E; Golusda L; Wolf J; Höpken UE; Scheidereit C; Kühl AA; Kolesnichenko M
J Pathol; 2020 Jun; 251(2):160-174. PubMed ID: 32222043
[TBL] [Abstract][Full Text] [Related]
5. Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.
Deuring JJ; Li M; Cao W; Chen S; Wang W; de Haar C; van der Woude CJ; Peppelenbosch M
PLoS One; 2019; 14(10):e0221924. PubMed ID: 31581194
[TBL] [Abstract][Full Text] [Related]
6. [Expression of zinc finger protein A20 in pediatric inflammatory bowel disease].
Zheng CF; Huang Y
Zhonghua Er Ke Za Zhi; 2011 Apr; 49(4):261-5. PubMed ID: 21624200
[TBL] [Abstract][Full Text] [Related]
7. WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease.
Zhang Q; Zhang C; Li X; Yu Y; Liang K; Shan X; Zhao K; Niu Q; Tian Z
Dis Markers; 2016; 2016():3547096. PubMed ID: 27403031
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease.
Papoutsopoulou S; Campbell BJ
Curr Pharm Des; 2021; 27(35):3702-3713. PubMed ID: 33602081
[TBL] [Abstract][Full Text] [Related]
9. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease.
Bradford EM; Ryu SH; Singh AP; Lee G; Goretsky T; Sinh P; Williams DB; Cloud AL; Gounaris E; Patel V; Lamping OF; Lynch EB; Moyer MP; De Plaen IG; Shealy DJ; Yang GY; Barrett TA
J Immunol; 2017 Sep; 199(5):1886-1897. PubMed ID: 28747340
[TBL] [Abstract][Full Text] [Related]
10. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
[TBL] [Abstract][Full Text] [Related]
12. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
Hollenbach E; Neumann M; Vieth M; Roessner A; Malfertheiner P; Naumann M
FASEB J; 2004 Oct; 18(13):1550-2. PubMed ID: 15289440
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells.
Takahashi Y; Sato S; Kurashima Y; Lai CY; Otsu M; Hayashi M; Yamaguchi T; Kiyono H
EBioMedicine; 2017 Sep; 23():34-45. PubMed ID: 28789943
[TBL] [Abstract][Full Text] [Related]
15. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.
Andoh A; Shioya M; Nishida A; Bamba S; Tsujikawa T; Kim-Mitsuyama S; Fujiyama Y
J Immunol; 2009 Jul; 183(1):687-95. PubMed ID: 19535621
[TBL] [Abstract][Full Text] [Related]
16. Ileal Crohn's Disease Exhibits Reduced Activity of Phospholipase C-β3-Dependent Wnt/β-Catenin Signaling Pathway.
Ando T; Takazawa I; Spencer ZT; Ito R; Tomimori Y; Mikulski Z; Matsumoto K; Ishitani T; Denson LA; Kawakami Y; Kawakami Y; Kitaura J; Ahmed Y; Kawakami T
Cells; 2024 Jun; 13(11):. PubMed ID: 38891118
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
Tian Y; Xu J; Li Y; Zhao R; Du S; Lv C; Wu W; Liu R; Sheng X; Song Y; Bi X; Li G; Li M; Wu X; Lou P; You H; Cui W; Sun J; Shuai J; Ren F; Zhang B; Guo M; Hou X; Wu K; Xue L; Zhang H; Plikus MV; Cong Y; Lengner CJ; Liu Z; Yu Z
Gastroenterology; 2019 Jun; 156(8):2281-2296.e6. PubMed ID: 30779922
[TBL] [Abstract][Full Text] [Related]
18. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
20. Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer.
Pu Z; Yang F; Wang L; Diao Y; Chen D
J Drug Target; 2021 Jun; 29(5):507-519. PubMed ID: 33307848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
